NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead. Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year. Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet. That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict. |
Third CIIE to create new opportunities for common developmentChina donates more PPEs to help Namibia fight COVIDXi's Speech at Meeting of Central Commission for Public Sector Reform to Be PublishedChina hands over first batch of vaccine donation to MaldivesChina successfully clones world's first Tibetan goatsKey Takeaways from Xi's State Visit to VietnamMeeting of EU Foreign Affairs Council held in BrusselsChina's second domesticallyChina's highly anticipated C919 passenger aircraft returns after debut at Singapore AirshowChina, France hold strategic dialogue